Terminated PHASE3 INTERVENTIONAL 1-arm NCT02318914

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients With Pyoderma Gangrenosum

Sponsor: XOMA (US) LLC

Interventions gevokizumab

Updated 7 times since 2017 Last updated: Apr 25, 2016 Started: Nov 30, 2014 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from XOMA (US) LLC

More terminations from XOMA (US) LLC

Other Pyoderma Gangrenosum trials with similar outcome

Browse all Pyoderma Gangrenosum trials

A PHASE3 clinical study on Pyoderma Gangrenosum, this trial is terminated or withdrawn. The trial is conducted by XOMA (US) LLC and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

XOMA (US) LLC

Data source: XOMA (US) LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Benowa, Australia , Birmingham, United States , Chicago, United States , Cincinnati, United States , Cleveland, United States , Columbus, United States , Coral Gables, United States , Farmington, United States and 30 more locations